🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating a targeted therapy as a possible treatmen...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-15
Trial ID
NCT04081259
Treatments Being Tested
This is a Phase I/Ib study in which the safety of the combination therapy o...
Status
Terminated
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2022-03-31
Trial ID
NCT04916236
This trial is an open-label, multicenter, Phase 0/2 trial that will enroll ...
Status
Completed
Location
Chandler Regional Medical Center
Start Date
2020-07-11
Trial ID
NCT04391595
Treatments Being Tested
The purpose of CTO-IUSCC-0730 study is to assess the clinical efficacy of L...
Status
Terminated
Location
Indiana University Hospital / IU Simon Cancer Center
Start Date
2020-10-05
Trial ID
NCT04534283
Treatments Being Tested
The main purpose of this study is to measure how much of the study drug get...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2019-08-01
Trial ID
NCT04033341
Treatments Being Tested
The purpose of this study is to determine the safety of an extracellular si...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2016-09-29
Trial ID
NCT02857270
Treatments Being Tested
This research is studying the safety of combining ibrutinib with the study ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-02-03
Trial ID
NCT04043845
This phase Ib/II trial investigates the side effects and best dose of LY321...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-12-02
Trial ID
NCT04616183
Treatments Being Tested
This study is evaluating the safety and efficacy of combining the study dru...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-05-27
Trial ID
NCT04386057
Treatments Being Tested